Where you find opportunities to grow

* Can't find your brand, product, service? Join BPT Marketplace

Caroline Green

Contributor Featured Research

Caroline represents Creative BioMart, a biotech company based in New York, providing quality GMP proteins, recombinant proteins, and other protein products to the research community of biology, clinical research, molecular diagnostics, and biopharmaceutical drug development.

   

coronavirus Healthcare Immunotherapy Antivirals Biotech Research Cell Therapies Stem-Cell Research/Therapy Gastroenterology Immunology and Inflammation Infectious Diseases (Bacterial and Viral) Oncology

Disclaimer: All opinions, ideas, and thoughts expressed and posted by Contributors at BiopharmaTrend.com platform are their own personal points of view, and do not represent neither Contributor's employers, nor BiopharmaTrend.com.

Posts by this author

New Study Shows Remdesivir Prevents Coronavirus MERS-CoV Infection In Monkeys

   518
New Study Shows Remdesivir Prevents Coronavirus MERS-CoV Infection In Monkeys

In a new study, researchers from the National Institutes of Health reported that the experimental antiviral drug remdesivir (also known as GS-5734) successfully prevented rhesus monkeys infected with the Middle East Respiratory Syndrome (MERS) coronavirus (MERS-CoV) from becoming ill from this virus infection. Giving remdesivir before infection can prevent them from getting sick, while giving this drug after they are infected can improve their condition. The results were published online February 13, 2020 in the journal PNAS, entitled "Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection".

The Key Role Of Stem Cells In Lethal Gastric Cancer Revealed

   325
The Key Role Of Stem Cells In Lethal Gastric Cancer Revealed

In a recent study published in Nature Communications, scientists from Cornell University made new findings in common and fatal gastric cancer research. In the United States, the incidence of gastroesophageal cancer increased 2.5-fold from the 1970s to the early 2000s, however, from the 1950s, the number of all patients with gastric cancer decreased by more than 80%; despite this, gastric cancer is still the fifth most common cancer and the third leading cause of cancer death worldwide.